CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Gravita India announces association with Korea Zinc; share gains over 5 per cent

Shreya Chaware 0 1793 Article rating: 3.5

On Monday, Gravita India Limited announced an annual agreement with Sorin Corporation, a subsidiary of Korea Zinc Co Limited for supplying approximately 8,000 MT of refined lead to be served in the calendar year 2021. Nevertheless, if calculated at the current lead prices, it would be an approximate contract value of Rs 125 crore.

Datamatics assists UTI mutual fund amid pandemic to set-up paperless digital workplace

Shreya Chaware 0 1172 Article rating: 5.0

Datamatics Global Services on Thursday announced that it has successfully implemented its digital workspace solution for UTI mutual fund, which involves digitising two of its critical processes to achieve a seamless flow of information, higher transparency, and agility across multiple offices.  

Dr Reddys gets safe recommendation for third phase of Sputnik V clinical trial

Shreya Chaware 0 872 Article rating: 3.7

Dr Reddy's Laboratories on Monday post-market hours informed that the independent Data & Safety Monitoring Board (DSMB) has reviewed the safety data from phase 2 clinical trial of Sputnik V vaccine and has given the approval to go ahead with phase 3 clinical trial after necessary prerequisites, without any modifications. 

KEC International climbs over 1 per cent on attaining new orders across various businesses

Shreya Chaware 0 1450 Article rating: 2.3

KEC International announced during the weekend that it has received new orders across its various businesses. The orders, which amount to up to Rs 1,024 crore in total, have been received in various segments such as transmission & distribution, railways, civil, solar, and cables.  

AU Small Finance Bank & ICICI Prudential Life Insurance collaborate for life insurance products

Shreya Chaware 0 1124 Article rating: 3.3

AU Small Finance Bank has informed that it has entered into a strategic partnership with ICICI Prudential Life Insurance Company to offer personalised insurance solutions to enhance the customer experience. The former aims to offer customised & goal-based life insurance solutions. 

Biocon Biologics to get Biologics licence application for cancer & eye disease medication

Shreya Chaware 0 777 Article rating: 3.5

Biocon Biologics Ltd (a subsidiary of Biocon Ltd) and Mylan (a subsidiary of Viatris Inc.) have been further informed by United States Food & Drug Administration (USFDA) regarding the deferral of the action on Biologics licence application (BLA) for MYL-1402O, a proposed biosimilar to Avastin® (Bevacizumab). 

Lupin obtains tentative nod for vaccine to cure toenail fungal infection disease

Shreya Chaware 0 896 Article rating: 2.7

Lupin Limited informed that it has received tentative approval from United States Food & Drug Administration for Efinaconazole topical solution, 10 per cent to market a generic equivalent of Jublia® topical solution, 10 per cent of Bausch Health Americas, Inc. This solution is used to cure Onychomycosis, a fungal infection caused in nails. 

Aurobindo Pharma takes a step forward to cure COVID-19; collaborates with US company COVAXX

Shreya Chaware 0 1447 Article rating: 3.7

On Thursday, Aurobindo Pharma, a leading pharma company, signed an exclusive agreement with COVAXX, a US-based company for developing and commercialising COVID-19 vaccine i.e. UB-612, the first multitope peptide-based vaccine to fight COVID-19, for India and United Nations Children's Fund (UNICEF) agency. 

Bajaj Auto gets nod from Maharashtra Government for Rs 650 crore investment; signs MoU

Shreya Chaware 0 884 Article rating: 5.0

Bajaj Auto Limited informed the bourses on Tuesday after the market hours that it has signed a memorandum of understanding (MoU) with the Government of Maharashtra for setting up a manufacturing facility on a proposed investment of Rs 650 crore in Chakan (Maharashtra). 

AstraZeneca Pharma opens door for severe & rare asthma treatment; stock slumps 3 per cent

Shreya Chaware 0 1197 Article rating: 2.5

AstraZeneca Pharma India Limited informed on Monday that it has been granted permission by Drugs Controller General of India (DCGI) for importing & marketing of Benralizumab 30mg/ml solution for injection (Fasenra™). The medicine helps in treating a severe & rare type of asthma caused mainly in adults. 

RSS
123456789

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR